Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Comparison of low eGFR prevalence and prediction for mortality using 2009 and 2021 CKD-EPI equations in Mexican adultsDaniel Ramírez-García, Carlos A Fermín-Martínez, Paulina Sánchez Castro, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 12, 2025
Comparison of Low eGFR Prevalence and Prediction for Mortality Using 2009 and 2021 CKD-EPI Equations in Mexican AdultsDaniel Ramírez-García, Carlos A Fermín-Martínez, Paulina Sánchez Castro, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Assessment of fatal cardiovascular disease risk using data-driven diabetes subgroups and SCORE2-Diabetes in 24,943 adults in Mexico CityJerónimo Perezalonso-Espinosa, Juan Pablo Díaz-Sánchez, Daniel Ramírez-García, et al.
Lancet Regional Health. Americas|April 30, 2026
Assessment of fatal cardiovascular disease risk using data-driven diabetes subgroups and SCORE2-Diabetes: a prospective, observational, population-based analysis of adults with diabetes in Mexico CityJerónimo Perezalonso-Espinosa, Juan Pablo Díaz-Sánchez, Daniel Ramírez-García, et al.
The Lancet. Public Health|August 26, 2023
Educational and social inequalities and cause-specific mortality in Mexico City: a prospective studyThomas Addey, Jesus Alegre-Díaz, Fiona Bragg, et al.
Diabetes Care|March 27, 2026
Metabolomic Profile of Genetic Liability to Type 2 Diabetes Among 125,000 Mexican Adults: A Mendelian Randomization StudyFiona Bragg, Jesus Alegre-Diaz, Eirini Trichia, et al.
Lancet Regional Health. Americas|February 24, 2026
External validation and recalibration of cardiovascular risk scores for prediction of 10-year risk of fatal cardiovascular disease: a prospective, observational, population-based cohort analysis of adults in Mexico CityJerónimo Perezalonso-Espinosa, Daniel Ramírez-García, Juan Pablo Díaz-Sánchez, et al.
Medrxiv : the Preprint Server for Health Sciences|September 18, 2025
External validation and recalibration of office- and laboratory-based cardiovascular risk scores for prediction of 10-year risk of fatal cardiovascular disease in 112,262 adults in Mexico CityJerónimo Perezalonso-Espinosa, Daniel Ramírez-García, Juan Pablo Díaz-Sánchez, et al.
Lancet Regional Health. Americas|April 17, 2025
Type 2 diabetes and cause-specific mortality in Mexico City: a Mendelian randomisation analysisFiona Bragg, Pablo Kuri-Morales, Eirini Trichia, et al.
International Journal of Epidemiology|July 12, 2025
A Mendelian randomization study of the effect of body mass index on 52 causes of death among 125 000 Mexican adults with admixed ancestryLouisa Gnatiuc Friedrichs, Pablo Kuri-Morales, Eirini Trichia, et al.
Pageof 9